Regulatory Leaning FibriCheck is a CE class IIa medical device with MHRA, FDA and TGA approvals, indicating strong compliance credentials and credibility in global markets. This creates sales opportunities with healthcare providers and distributors who prioritize certified software solutions for cardiac care.

Widespread Adoption Used by over 2000 clinical practices and trusted by more than 1 million users across 43 countries, highlighting a proven network effect and ready-made case studies to accelerate enterprise sales and partnerships.

Device-Agnostic Offers a software-only, device-agnostic PPG solution that works with smartphone cameras and integrates with various platforms, enabling easier integration with hospital EHR systems and remote monitoring programs without hardware constraints.

Strategic Partnerships Existing collaborations with NHS-related remote monitoring and Arrhythmia Alliance, plus co-development via Data Registry, present opportunities to expand for national health services, research partnerships, and payer-supported programs.

Expansion Signals Recent product launches including Samsung Galaxy watch integration and award recognitions signal market momentum and potential upsell opportunities to wearables-focused care pathways and enterprise customers seeking mobile health capabilities.